Philippe Gaulard

Top papers

• CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

  Bertrand Coiffier, Éric Lepage, Josette Brière, et al.·2002·New England Journal of Medicine
  ↗ 5,535OA
• Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

  Pierre Feugier, Ambro van Hoof, Catherine Sebban, et al.·2005·Journal of Clinical Oncology
  ↗ 1,497
• The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

  Elı́as Campo, Elaine S. Jaffe, James R. Cook, et al.·2022·Blood
  ↗ 1,436OA
• Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

  Andreas Rosenwald, George W. Wright, Karen Leroy, et al.·2003·The Journal of Experimental Medicine
  ↗ 1,099OA
• Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

  Stefano Pileri, Thomas M. Grogan, Nancy L. Harris, et al.·2002·Histopathology
  ↗ 663
• The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

  Laurence de Leval, David S. Rickman, Caroline Thielen, et al.·2007·Blood
  ↗ 618OA
• Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

  Frédéric Peyrade, Fabrice Jardin, Catherine Thiéblemont, et al.·2011·The Lancet Oncology
  ↗ 537
• Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

  Javeed Iqbal, George W. Wright, Chao Wang, et al.·2014·Blood
  ↗ 534OA
• IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma

  Rob A. Cairns, Javeed Iqbal, François Lemonnier, et al.·2012·Blood
  ↗ 499OA
• [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

  Corinne Haïoun, Emmanuel Itti, Alain Rahmouni, et al.·2005·Blood
  ↗ 497OA
• Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters

  François Lemonnier, Lucile Couronné, Marie Parrens, et al.·2012·Blood
  ↗ 491OA
• Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

  Christian Gisselbrecht, Philippe Gaulard, Éric Lepage, et al.·1998·PubMed
  ↗ 438